These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10888348)

  • 21. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A; Bera JC; Collet L
    Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-dependent suppression of transient evoked and distortion product otoacoustic emissions by a low-frequency tone.
    Scholz G; Mrowinski D; Hensel J
    Audiology; 1999; 38(5):271-5. PubMed ID: 10548375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of aging on distortion-product otoacoustic emissions in adults with normal hearing.
    Uchida Y; Ando F; Shimokata H; Sugiura S; Ueda H; Nakashima T
    Ear Hear; 2008 Apr; 29(2):176-84. PubMed ID: 18595184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transiently evoked otoacoustic emissions in patients with Menière's disease.
    Harris FP; Probst R
    Acta Otolaryngol; 1992; 112(1):36-44. PubMed ID: 1575035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: time course of recovery and effects of lowering L2.
    Sutton LA; Lonsbury-Martin BL; Martin GK; Whitehead ML
    Hear Res; 1994 May; 75(1-2):161-74. PubMed ID: 8071143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the Compressive Nonlinearity of the Cochlea During Early Aging: Estimates From Distortion OAE Input/Output Functions.
    Ortmann AJ; Abdala C
    Ear Hear; 2016; 37(5):603-14. PubMed ID: 27232070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distortion product otoacoustic emission levels and input/output-growth functions in normal-hearing individuals with tinnitus and/or hyperacusis].
    Bartnik G; Hawley M; Rogowski M; Raj-Koziak D; Fabijanska A; Formby C
    Otolaryngol Pol; 2009; 63(2):171-81. PubMed ID: 19681492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditory function in normal-hearing, noise-exposed human ears.
    Stamper GC; Johnson TA
    Ear Hear; 2015; 36(2):172-84. PubMed ID: 25350405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The application of otoacoustic emission registration in the diagnosis of Meniere's disease].
    Pal'chun VT; Levina IuV
    Vestn Otorinolaringol; 1999; (6):5-8. PubMed ID: 10596591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related changes in transiently evoked otoacoustic emissions and distortion product otoacoustic emissions in normal-hearing ears.
    Satoh Y; Kanzaki J; O-Uchi T; Yoshihara S
    Auris Nasus Larynx; 1998 May; 25(2):121-30. PubMed ID: 9673723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis.
    Magliulo G; Cianfrone G; Gagliardi M; Cuiuli G; D'Amico R
    Ann Otol Rhinol Laryngol; 2004 Dec; 113(12):1000-5. PubMed ID: 15633904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic significance of transiently evoked otoacoustic emissions in meniere's disease].
    Li Q; Zhong N
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 13(10):435-7. PubMed ID: 12541392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of age on contralateral suppression of distortion product otoacoustic emissions in human listeners with normal hearing.
    Kim S; Frisina DR; Frisina RD
    Audiol Neurootol; 2002; 7(6):348-57. PubMed ID: 12401966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distortion product oto-acoustic emissions as objective audiometry in a group of children with ventilation tubes.
    Gordts F; Naessens B; Meyvisch P; Clement PA
    Scand Audiol; 1999; 28(2):97-100. PubMed ID: 10384897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between distortion product otoacoustic emissions and frequency modulation difference limens.
    Krishnamurti S
    Ear Hear; 2000 Aug; 21(4):305-9. PubMed ID: 10981606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.